Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice
D. Moneta(Mario Negri Institute for Pharmacological Research), Annamaria Vezzani(Mario Negri Institute for Pharmacological Research), Jean‐Marie Billard(Inserm), P. Dutar(Unknown), Jason Hannon(Novartis (Switzerland)), Marisa Aliprandi(Mario Negri Institute for Pharmacological Research), Dominique Fehlmann(Novartis (Switzerland)), Pascal Dournaud(Délégation Paris 7), Cristina Richichi(European Institute of Oncology), Caroline Nunn(Novartis (Switzerland)), Daniël Hoyer(Complexity Science Hub), Cécile Viollet, Jacques Epelbaum(Centre National de la Recherche Scientifique), Anne-Sophie Carlo(Inserm)
Cited by 86
Related Papers
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Brain Inflammation in Epilepsy: Experimental and Clinical Evidence
|Epilepsia|2005|1k
Interleukin-1β Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures
|Journal of Neuroscience|1999|567
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488